Clinical trial
Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and…
NCT00158457 · French National Agency for Research on AIDS and Viral Hepatitis, Other · Completed
Key facts
| NCT number | NCT00158457 |
|---|---|
| Title | Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207) |
| Official title | Pilot Trial to Evaluate the Efficacy and Tolerance of a Simple Once Daily Combined Regimen Including Tenofovir (TDF), Emtricitabine (FTC) and Efavirenz (EFV) in HIV-1 Infected Patients Naive to Prior Antiretroviral Treatment in Senegal |
| Lead sponsor | French National Agency for Research on AIDS and Viral Hepatitis, Other |
| Collaborators | Gilead Sciences Industry Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | Tenofovir (TDF), Emtricitabine (FTC), Efavirenz (EFV) |
| Enrollment | 40 |
| Start date | Jun 1, 2004 |
| Completion | Dec 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Jul 3, 2007 |
| Countries | Senegal |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: